產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時服務熱線
HEC-1-A (人子宮內膜腺癌細胞) (STR鑒定正確)
貨號：CL-0099
規(guī)格：1×10?cells/T25培養(yǎng)瓶
價格： ￥1400
生長培養(yǎng)基：McCoy’s 5A＋10% FBS＋1% P/S
產(chǎn)品概述
| 名稱 | HEC-1-A (人子宮內膜腺癌細胞) (STR鑒定正確) |
| 別稱 | Hec-1-A; HEC-1A; HEC1-A; HEC1A; Hec1A |
| 種屬 | 人 |
| 生長特性 | 貼壁細胞 |
| 細胞形態(tài) | 上皮細胞樣 |
| 凍存條件 | 凍存液：55% 基礎培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認） |
生長培養(yǎng)基:
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:3-1:4 |
| 推薦換液頻率 | 2-3次/周 |
| 背景描述 | HEC-1-A細胞及其亞株HEC-1-B細胞是H·Kuramoto及其同事于1968年從一位ⅠA期子宮內膜癌患者身上分離得到的。PAF可以誘導，HEC-1-A細胞c-fos的表達。 |
| 年齡（性別） | 女性；71歲 |
| 組織來源 | 腺癌；子宮；子宮內膜炎 |
| 細胞類型 | 腫瘤細胞 |
| 腫瘤類型 | 子宮內膜腺癌 |
| 生物安全等級 | BSL-1 |
| 倍增時間 | ~27-36 hours |
| 致瘤性 | Yes, in nude mice (The cells form moderately well differentiated adenocarcinomas consistent with endometrial carcinoma (grade II)).Yes, in the cheek pouch of cortisone treated hamsters (The cells form typical papillary adenomas). |
| 受體表達情況 | platelet activating factor (PAF) |
| 抗原表達情況 | Blood Type B; Rh+ |
| 基因表達情況 | c-fos+ |
| 保藏機構 | ATCC; HTB-112 BCRC; 60552 JCRB; JCRB1117 JCRB; NIHS0388 |
STR鑒定
-
STR位點信息
Amelogenin X CSF1PO 10,12 D2S1338 18,19 D3S1358 15 D5S818 11,15 D7S820 9,11 D8S1179 13,14 D13S317 11 D16S539 12 D18S51 16,21 D19S433 13 D21S11 30,31 FGA 21,22 PentaD 9,12,13 PentaE 11 TH01 6,7 TPOX 8,11 vWA 18,19,20 D6S1043 12,18 D12S391 19 D2S441 11,13 -
STR鑒定圖
-
參考文獻
-
Construction of the novel immune risk scoring system related to CD8+ T cells in uterine corpus endometrial carcinoma(2023/06/22)
作者：Ganghua Zhang, Zhijing Yin, Jianing Fang
期刊：Cancer Cell International
DOI：10.1186/s12935-023-02966-y
影響因子 ：5.800
-
Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer(2023/09/05)
作者：Chenyang Wang, Jing Li, Weina Liu
期刊：Aging-US
影響因子 ：5.200
引用產(chǎn)品：CL-0099
-
Mechanism of action of icaritin on uterine corpus endometrial carcinoma based on network pharmacology and experimental evaluation(2023/07/19)
作者：Yanbin Jin , Xiaochen Liang, Junhong Cai
期刊：Frontiers in Oncology
影響因子 ：4.700
引用產(chǎn)品：CL-0099
-
Downregulation of PSAT1 inhibits cell proliferation and migration in uterine corpus endometrial carcinoma(2023/03/11)
作者：Wang Min, Yue Song, Yang Zhu
期刊：Scientific Reports
DOI：10.1038/s41598-023-31325-0
影響因子 ：4.600
引用產(chǎn)品：CL-0099
-
SIM2: Its Prognostic Significance and Oncogenic Role in Endometrial Carcinoma(2024/01/26)
作者：Yunfang Wei, Xianlei Zhao, Hong Tang
期刊：OncoTargets and Therapy
影響因子 ：4.000
引用產(chǎn)品：CL-0099
-
Ferroptosis-related lncRNA model based on CFAP58-DT for predicting prognosis and immunocytes infiltration in endometrial cancer(2023/02/10)
作者：Aijun Qin, Qiaoxia Qian, Xiaopei Cui
期刊：Annals of Translational Medicine
影響因子 ：3.616
-
CMBs carrying PTX and CRISPR/Cas9 targeting C?erbB?2 plasmids interfere with endometrial cancer cells(2021/9/30)
作者：Siyuan Peng, Junhong Cai, Shan Bao
期刊：Molecular Medicine Reports
影響因子 ：3.400
引用產(chǎn)品：CL-0099
-
ZAP70 interaction with 13 mRNAs as a potential immunotherapeutic target for endometrial cancer(2023/04/06)
作者：Yuming Zhang, Haiou Lu, Yuexin Yu
期刊：Oncology Letters
影響因子 ：2.900
-
Friend leukemia integration 1 overexpression decreases endometrial receptivity and induces embryo implantation failure by promoting PART1 transcription in the endometrial epithelial cells(2023/09/26)
作者：Yile Zhang, Beining Yin, Sichen Li
期刊：PeerJ
影響因子 ：2.700
-
Effects of RFRP?3 on an ovariectomized estrogen?primed rat model and HEC?1A human endometrial carcinoma cells(2022/12/23)
作者：Xueying Zhao, Lina Si, Lin Niu
期刊：Experimental and Therapeutic Medicine
影響因子 ：2.700
引用產(chǎn)品：CL-0099
-
IGFBP?rP1 affects the proliferation, apoptosis and macrophage polarization of endometrial cancer cells by regulating the PI3K/AKT pathway(2023/03/03)
作者：Juan Gao, Shiqi Suo, Jingxia Li
期刊：Experimental and Therapeutic Medicine
影響因子 ：2.700
-
Activation of MAL2 by RAD21 inhibits the expression of MHC-I in immune evasion of endometrial cancer(2024/04/24)
作者：Yuni Jin, Xiaoning Lu, Yuan Liu
期刊：CYTOTECHNOLOGY
DOI：10.1007/s10616-024-00629-y
影響因子 ：2.200
引用產(chǎn)品：CL-0099
-
LINC01857 Exacerbates the Malignant Behaviors of Endometrial Carcinoma Cells by Sponging miR-19b-3p and Recruiting ELAVL1 to Upregulate MYCN(2023/03/28)
作者：Rong Cao, Jiao Zhao, Jingru Zhang
期刊：GYNECOLOGIC AND OBSTETRIC INVESTIGATION
影響因子 ：2.100
引用產(chǎn)品：CL-0099
-
Growth hormone inhibits the JAK/STAT3 pathway by regulating SOCS1 in endometrial cells in vitro: A clue to enhance endometrial receptivity in recurrent implantation failure(2022/12/22)
作者：Haixia Li, Ning Su, Yaqiao Zhu
期刊：EUROPEAN JOURNAL OF HISTOCHEMISTRY
影響因子 ：1.966
引用產(chǎn)品：CL-0099
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識別碼示意圖
![NCI-H2228 [H2228; H-2228] (人肺癌細胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0570-1-1.jpg)
